Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice Standards
Integrative oncology (IO) programs are committed to offer evidence-based complementary medicine within conventional cancer care, addressing quality of life-related concerns. As part of a multidisciplinary team, clinical pharmacists provide guidance on potential effectiveness and safety of herbal supplement use, identifying potential toxicities and herb-drug interactions. In this commentary, we discuss the need to establish clinical competencies based on a structured training syllabus addressing patients' preferences and expectations, while ensuring safe IO practices.
Authors
- Noah Samuels (ORCID: https://orcid.org/0000-0002-1122-9607)
- Eran Ben‐Arye (ORCID: https://orcid.org/0000-0002-4058-3672)
- Alexandre Chan (ORCID: https://orcid.org/0000-0003-4391-4219)
- Sunita Vohra (ORCID: https://orcid.org/0000-0002-6210-7933)
Institutions
- University of Alberta (CA)
- Technion – Israel Institute of Technology (IL)
- Hebrew University of Jerusalem (IL)
- Shaare Zedek Medical Center (IL)
- Bikur Cholim Hospital (IL)
- Duke-NUS Medical School (SG)
- National Cancer Centre Singapore (SG)
- Clalit Health Services (IL)
Publication Details
- Journal
- Clinical Pharmacology & Therapeutics
- Published
- 2026-11-04
- DOI
- https://doi.org/10.1002/cpt.70559
- Primary Topic
- Complementary and Alternative Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00